Your browser doesn't support javascript.
loading
Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials.
Simpson, Eric L; Merola, Joseph F; Silverberg, Jonathan I; Reich, Kristian; Warren, Richard B; Staumont-Sallé, Delphine; Girolomoni, Giampiero; Papp, Kim; de Bruin-Weller, Marjolein; Thyssen, Jacob P; Zachariae, Rebecca; Olsen, Christiana K; Wollenberg, Andreas.
Affiliation
  • Simpson EL; Department of Dermatology, Oregon Health & Science University, Portland, OR, USA.
  • Merola JF; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Silverberg JI; Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
  • Reich K; Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, and NIHR Biomedical Research Centre, The University of Manchester, Manchester, UK.
  • Staumont-Sallé D; Dermatology Service, Lille University Hospital, Inserm U1286 INFINITE (Institute for Translational Research in Inflammation), Lille University, Lille, France.
  • Girolomoni G; Section of Dermatology, Department of Medicine, University of Verona, Verona, Italy.
  • Papp K; Probity Medical Research and K Papp Clinical Research, Waterloo, ON, Canada.
  • de Bruin-Weller M; National Expertise Center for Atopic Dermatitis, Department of Dermatology/Allergology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Thyssen JP; Department of Dermatology and Venereology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Zachariae R; LEO Pharma A/S, Ballerup, Denmark.
  • Olsen CK; LEO Pharma A/S, Ballerup, Denmark.
  • Wollenberg A; Klinikum der Universität München, Klinik und Poliklinik für Dermatologie und Allergologie, Munich, Germany.
Br J Dermatol ; 187(6): 888-899, 2022 12.
Article in En | MEDLINE | ID: mdl-36082590

Full text: 1 Database: MEDLINE Main subject: Respiratory Tract Infections / Skin Diseases, Infectious / Conjunctivitis / Dermatitis, Atopic / Kaposi Varicelliform Eruption Type of study: Clinical_trials Limits: Adult / Humans Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Respiratory Tract Infections / Skin Diseases, Infectious / Conjunctivitis / Dermatitis, Atopic / Kaposi Varicelliform Eruption Type of study: Clinical_trials Limits: Adult / Humans Language: En Year: 2022 Type: Article